If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -2.50 (-1.18%)
Bid:
208.00
Ask:
211.00
Spread: 3.00 (1.442%)
Market Cap: £580.47m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Director/PDMR Shareholding

23 Aug 2010 12:52

RNS Number : 4782R
Morgan Crucible Co PLC
23 August 2010
 



Notification of interests of person discharging managerial responsibility ("PDMR")

23 August 2010

This notification is made pursuant to DTR 3.1.4R (1)(a).

The Company announces that on 16 August 2010 an award over ordinary 25p shares in the Company were made to the PDMR listed below under the Company's Long Term Incentive Plan 2004 ("LTIP"). 

The award under the LTIP is structured as an Approved Performance Share Plan ("APSP") award and comprises three elements: (i) an HM Revenue & Customs approved option over shares to the value of the first £30,000 worth of the award with an exercise price of 213.2 pence per share; (ii) an LTIP award in the form of a conditional award of free shares to the value of the remainder of the award above this limit; and (iii) a funding award, also in the form of a conditional award of free shares, over such number of shares whose value at exercise of the approved option equals £30,000. 

Subject to satisfaction of performance targets, 50% based on TSR against the comparator group and 50% based on EPS growth above RPI, awards under the LTIP will vest in three years' time.

In addition to satisfaction of the performance targets, the approved option and the associated funding award will only vest in the event that the market value of a share at vesting is greater than 213.2 pence per share. The funding award is solely used to fund the exercise price of the approved option and will be satisfied by shares from the Company's employee benefit trust. Following vesting of the funding award, these shares are retained by the trust and not delivered to the participant. 

Name

Number of shares subject to award (approved option and LTIP award)

Maximum number of shares subject to funding award (not delivered to participant)

Spencer Evans

32,833

14,071

 

Following the grant of the award detailed above, the total number of shares in respect of which awards are held by Mr Evans pursuant to the Company's Long Term Incentive Plan is detailed below:

Name

Total Number of Shares held pursuant to LTIP awards

Spencer Evans

32,833

 

Enquiries: Tracey Bigmore, The Morgan Crucible Company plc,

01753 837000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFELTLIVFII
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 202412:01 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 202410:58 amRNSHolding(s) in Company
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Update
5th Nov 20247:00 amRNSCommencement of Share Buyback Programme
1st Oct 202412:03 pmRNSHolding(s) in Company
23rd Aug 202412:59 pmRNSHolding(s) in Company
20th Aug 20248:58 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSHalf-year results
24th Jul 20247:00 amRNSDirectorate Change
17th Jun 202410:01 amRNSBlock listing Interim Review
13th Jun 20249:32 amRNSDirector/PDMR Shareholding
12th Jun 202412:05 pmRNSDirector/PDMR Shareholding
3rd Jun 20243:52 pmRNSDirector/PDMR Shareholding
22nd May 20245:17 pmRNSDirector/PDMR Shareholding
10th May 20245:21 pmRNSDirector/PDMR Shareholding
9th May 20241:59 pmRNSResult of AGM
9th May 20247:00 amRNSQ1 Trading Update
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.